Ana Paula Tediosi

Ana Paula Tediosi is a seasoned expert in the pharmaceutical and biotechnology sectors, currently serving as the Head of Expanded Access Program Strategy and Director of Business Development at WEP Clinical since January 2024. With a strong background in managing expanded access programs, Ana has held pivotal roles at high-profile companies including Stemline Therapeutics, Roche, and Bristol-Myers Squibb, focusing on strategy development, contract negotiations, and program implementation in oncology and other therapeutic areas. Ana is also the founder of Birdhaus Writing & Publishing and Birdhaus Social, a coworking space in Zurich for women, showcasing a commitment to empowering women in the writing community. Ana holds both a Master's and Bachelor's degree in Pharmacy from the University of Geneva.